about
FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chanceChemotherapy-related late adverse effects on ovarian function in female survivors of childhood cancer and cancer in the reproductive ageThe time is now for a new approach to primary ovarian insufficiencyOne world, one womanAssociation of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risksA prospective evaluation of antral follicle function in women with 46,XX spontaneous primary ovarian insufficiencyMutations in NR5A1 associated with ovarian insufficiencyToward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for womenThe role of autoimmunity in premature ovarian failureThe developmental origins of the mammalian ovarian reserveA new approach to primary ovarian insufficiencyPharmacogenetics of follicle-stimulating hormone actionControl of Oocyte Reawakening by Kit.Premature ovarian insufficiency: the context of long-term effectsUpdate on primary ovarian insufficiencyCSB-PGBD3 Mutations Cause Premature Ovarian FailureFrom victim to survivor to thriver: helping women with primary ovarian insufficiency integrate recovery, self-management, and wellnessExome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instabilityMCM9 mutations are associated with ovarian failure, short stature, and chromosomal instabilityPremature menopause or early menopause: long-term health consequencesThe ageing ovary and uterus: new biological insightsGlutamate Cysteine Ligase Modifier Subunit (Gclm) Null Mice Have Increased Ovarian Oxidative Stress and Accelerated Age-Related Ovarian FailureDefining ovarian reserve to better understand ovarian agingThe Flat Earth Society: a rose by any other name?A clinical research integration special program (CRISP) for young women with primary ovarian insufficiencyAn open letter to the primary ovarian insufficiency communityMutations in eIF4ENIF1 are associated with primary ovarian insufficiency.Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an updateNovel methods of treating ovarian infertility in older and POF women, testicular infertility, and other human functional diseases.Blood cell mitochondrial DNA content and premature ovarian aging.Polymerase chain reaction, nuclease digestion, and mass spectrometry based assay for the trinucleotide repeat status of the fragile X mental retardation 1 gene.CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles.Anti-Müllerian hormone deficiency in females with Fanconi anemia.Mutations in MSH5 in primary ovarian insufficiency.Gonadal expression of Foxo1, but not Foxo3, is conserved in diverse Mammalian species.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelineEffects of Bushen Tianjing Recipe in a rat model of tripterygium glycoside-induced premature ovarian failureEvaluation of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Red Blood Cell Distribution Width-Platelet Ratio for Diagnosis of Premature Ovarian Insufficiency.Rheumatic autoimmune diseases in women and midlife healthPathogenesis and causes of premature ovarian failure: an update.
P2860
Q21135603-9CBEC72B-0D5E-4B23-B1A7-5F82D0A03E44Q24234171-12324579-10CB-4E44-90CE-04872D791994Q24594274-BE883099-BD3B-4D67-83FE-EBD3E71719C8Q24612879-CAC5A7E6-210C-4234-9966-F2A48EF54772Q24621546-930AC8E1-7A94-457D-ACF9-E06AF09C4493Q24632502-6802608B-64A1-4061-8E5F-49D40111773DQ24655709-AAEA95F2-BA23-4A4D-8548-84133F7C6CCEQ26771979-8E53F0E7-A76B-4AD9-83C2-CC1C124682F2Q26777105-5777A670-CC85-4843-9B2F-EB1183082B45Q26798856-D01F838A-1D56-4296-BC98-9F4E17E28DEEQ26859812-25360D15-AB2D-4557-A3F5-4F226244773AQ27009516-FA822288-BC59-4107-A95D-B4863FB20233Q27308132-8F32A0B6-AE75-4212-8B63-5320C85A9ED2Q28079341-2022C18B-67ED-4A76-B15E-76C82849E587Q28085503-009170D1-D67D-4951-8BFE-0CC2E2A12A03Q28115810-9EC01EC4-9CBA-4F4F-8AA9-F03632213912Q28249608-AD5D63E8-D244-40DD-A06C-DA79E99C6D1EQ28252485-6A458552-D22A-434B-A5C5-16E6AF741119Q28253387-C1EDF9D0-167D-4F80-98AD-3E4B46845CDFQ28257628-214F996B-977B-4DE1-9DB9-7E727C1FA257Q28278102-013BD850-0B61-43B6-B5AF-82FC9B4C1491Q28386151-2E15153A-B748-4CFC-A1F1-0FA228EEA3B6Q28386414-200DFA0C-C48B-486B-9838-657D619EBB1AQ28660485-A9EB6139-49C6-42C3-9E1E-DFEA974BAC7FQ28972322-B9EF0596-C3C5-40D6-9EAD-E92D94E3358AQ28972570-4C94BFE4-7BF3-4142-8516-9DC77E444CC1Q30358065-3A3309AE-9E39-4F54-896F-296EA0AD5890Q30430877-D1C4D549-F177-43B6-99CB-37D6CA30EA6DQ30645234-9C1F74F2-54ED-4C6C-B16B-4B69F07E1E50Q31083169-CB721A77-6C1B-45DD-A6A3-22F764A3F513Q33465181-A117693A-5FD4-4A2A-B2FF-749EA45876FBQ33567772-F5940A4E-D8B7-42B9-BB65-DD4EAF6E076CQ33569005-3DF224CE-AD94-49FB-A022-D80AB08B3371Q33569127-B0D276FD-0048-4912-9B2A-C213F5462CE2Q33581604-F92402B3-709A-4258-AD7A-30477A2A6B41Q33587845-9F63443B-18A0-4C60-BA8B-D5334A593757Q33594483-D3DC1D01-6C1E-4393-8443-17876413A593Q33716354-EE241523-03C3-4DE8-BA14-91D4247F7D82Q33727015-21F212D3-7636-47A5-BE46-85CD23A825A8Q33764453-945A097F-E897-4607-BD92-C78F360854B0
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clinical practice. Primary ovarian insufficiency
@ast
Clinical practice. Primary ovarian insufficiency
@en
Clinical practice. Primary ovarian insufficiency
@nl
type
label
Clinical practice. Primary ovarian insufficiency
@ast
Clinical practice. Primary ovarian insufficiency
@en
Clinical practice. Primary ovarian insufficiency
@nl
prefLabel
Clinical practice. Primary ovarian insufficiency
@ast
Clinical practice. Primary ovarian insufficiency
@en
Clinical practice. Primary ovarian insufficiency
@nl
P2860
P3181
P356
P1476
Clinical practice. Primary ovarian insufficiency
@en
P2093
Lawrence M Nelson
P2860
P304
P3181
P356
10.1056/NEJMCP0808697
P407
P577
2009-02-05T00:00:00Z